Psoriasis: all 1,928 studies

Page 17 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of DD-25 Topical Cream for the Treatment of Psoriasis Vulgaris : Proof of Concept StudyStatus unknownNCT01702324Phase 1/2
• Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic PatientsCompletedNCT01687582Not applicable
• A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific CountriesCompletedNCT01677598
• A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118Status unknownNCT01670513Phase 1/2
• Clinical Study of PET/CT and Association With Metabolic Syndrome/Depressive Symptoms in PsoriasisStatus unknownNCT01661127
• TNF-alfa Inhibitors and Antibody Production in Patients With PsoriasisStatus unknownNCT01657513Not applicable
• The Efficacy Of A Dead Sea Mineral Enriched Body Cream vs Its Carrier as an Adjuvant Treatment For Psoriatic PatientsStatus unknownNCT01651559
• SHP-141C in Plaque Type PsoriasisCompletedNCT01646567Phase 1
• A Study of Escalating Doses of Itacitinib Administered Orally in Patients With Plaque PsoriasisCompletedNCT01634087Phase 2
• The Effect of Alga Dunaliella Bardawil on PsoriasisStatus unknownNCT01628081Phase 3
• Assessing the Long Term Effectiveness and Safety of Biotherapies in the Treatment of Cutaneous PsoriasisCompletedNCT01617018
• miRNAs and mRNAs in PsoriasisStatus unknownNCT01604902
• Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis VulgarisCompletedNCT01595997Phase 1/2
• Optimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP)CompletedNCT01587755Phase 4
• A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT01585233Phase 2
• Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque PsoriasisCompletedNCT01582932Phase 1
• Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe PsoriasisCompletedNCT01577550Phase 1
• Efficacy of Aerosal® in the Treatment of Inverse Psoriasis and SebopsoriasisWithdrawnNCT01574872Phase 2
• A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical Exposition With EGFStatus unknownNCT01566578Phase 1
• Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque PsoriasisCompletedNCT01563068Phase 1
• A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp PsoriasisStatus unknownNCT01558310Phase 4
• Adalimumab-psoriasis and Small Bowel LesionsCompletedNCT01556672Phase 4
• An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque PsoriasisCompletedNCT01555606
• Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic PatientsCompletedNCT01539915Phase 1
• Distribution of Secukinumab (AIN457) Into Dermal Interstitial Fluid After a Single Subcutaneous Administration of 300 mgCompletedNCT01539213Phase 1
• Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in PsoriasisCompletedNCT01538342Not applicable
• Influence of Atorvastatin on Psoriasis Severity and Endothelial FunctionWithdrawnNCT01527097Phase 3
• Monitoring and Modifying Atherosclerosis in Psoriasis Patients StudyTerminatedNCT01522742
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With PsoriasisCompletedNCT01510951Phase 1
• The Impact of Targeted Therapy on Microorganism in Patients With PsoriasisStatus unknownNCT01504113
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With PsoriasisTerminatedNCT01493518Phase 1
• A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe PsoriasisCompletedNCT01488201Phase 1
• A Study of the Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With Moderate to Severe Plaque PsoriasisCompletedNCT01484587Phase 1
• An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis VulgarisCompletedNCT01466478Phase 1
• Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis VulgarisCompletedNCT01465282Phase 2
• A Survey on the Role and Benefits of Online Social Networks on Filipino Patients With PsoriasisCompletedNCT01465061
• Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque TestCompletedNCT01462643Phase 2
• The Effect of Glucagon Like Peptide (GLP)-1 in PsoriasisCompletedNCT01460069Not applicable
• GLP-1 Receptors in Normal Skin and Skin From Patients With PsoriasisStatus unknownNCT01451905Not applicable
• Study in Patients With Mild to Moderate PsoriasisCompletedNCT01451346Phase 1/2
• Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2Status unknownNCT01443338Phase 4
• Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With PsoriasisStatus unknownNCT01439425Phase 4
• Post Marketing Surveillance To Observe Safety And Efficacy Of Enbrel In Pediatric Patients With PsoriasisWithdrawnNCT01432249
• Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in PsoriasisWithdrawnNCT01429870Phase 4
• Systematic Review And Meta-Analysis Of Psoriasis Treatments.CompletedNCT01425138
• Assessment for Tachyphylaxis to Topical Corticosteroids in the Treatment of PsoriasisCompletedNCT01404338Phase 1
• BOSTRIP: Biomarkers of Systemic Treatment Response in PsoriasisTerminatedNCT01403012
• Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe PsoriasisCompletedNCT01384630Phase 2
• Psoriasis and the Risk of Cardiovascular Disease. A Prospective StudyStatus unknownNCT01382784
• A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque PsoriasisCompletedNCT01373567Phase 4
• Study to Test the Effectiveness of a New Treatment for Scalp PsoriasisSuspendedNCT01368887Phase 2
• Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque TestCompletedNCT01360944Phase 2
• Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic AgentsCompletedNCT01356758
• Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant PsoriasisCompletedNCT01356004Phase 4
• Psoriasis and Climate Therapy- Effect of Motivational Follow- up Calls on Clinical and Health Economic ParametersStatus unknownNCT01352780Phase 3
• Efficacy of Vitamin D3 for the Treatment of Psoriatic Patients With Vitamin D Deficiency and InsufficiencyStatus unknownNCT01339741Not applicable
• Fumaric Acid Versus Fumaric Acid Plus Narrow Band Type B Ultraviolet (UVB) for PsoriasisCompletedNCT01321164Phase 3
• Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis VulgarisCompletedNCT01320774
• Cell Responses to IFN-gammaTerminatedNCT01317017Early Phase 1
• Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis PatientsCompletedNCT01301157Phase 2
• A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis VulgarisCompletedNCT01297166Phase 1
• Clinical Trial to Investigate Efficacy of LAS41004 in PsoriasisCompletedNCT01283698Phase 2
• Open Clinical Study, Comparing Non-inferiority of Chronic Plaque PsoriasisSuspendedNCT01279629
• A Study to Assess the Clinical Profile of Patients in Spain With Moderate to Severe Psoriasis.CompletedNCT01262534
• First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals of Biologic and Clinical EffectsTerminatedNCT01261767Phase 1
• Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.WithdrawnNCT01260844Phase 1
• Safety Study of Ointment for the Treatment of Plaque-type PsoriasisCompletedNCT01258088Phase 1
• Efficacy Study of Two Choices of Phototherapy on Itching Skin DiseasesCompletedNCT01254240Phase 2
• Randomized Study of PH-10 for PsoriasisCompletedNCT01247818Phase 2
• Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors TherapyStatus unknownNCT01237262Phase 4
• Regulatory T-cells in Psoriasis Patients as Targets for TherapyCompletedNCT01233583
• Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque PsoriasisCompletedNCT01230138Phase 2
• Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis VulgarisCompletedNCT01229098Phase 2
• Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With PsoriasisCompletedNCT01229085Phase 3
• Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone FuroateSuspendedNCT01228656Phase 2
• Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects?Status unknownNCT01228409Phase 4
• Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With PsoriasisStatus unknownNCT01223976Phase 4
• ACT-128800 in Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT01208090Phase 2
• Study to Evaluate Vectical in Combination With Clobex Spray to Treatment Plaque PsoriasisCompletedNCT01205880Phase 4
• Apremilast for Chronic Plaque Psoriasis (CPP) Patients Who Have Failed One Course of Biologic TherapyWithdrawnNCT01200264Phase 2
• Efficacy Study of TEPSO® Socks in Improving Palmoplantar PustulosisTerminatedNCT01197989Phase 2
• Efficacy Study of TEPSO® Socks in Improving Palmoplantar PsoriasisCompletedNCT01197976Phase 2
• Dose Ranging Study to Compare the Efficacy and Safety of Methotrexate in Plaque Type PsoriasisCompletedNCT01187264Phase 4
• Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep ApneaCompletedNCT01181570Phase 4
• Improving Psoriasis Through Health and Well-BeingCompletedNCT01162252Not applicable
• Determination of the Efficacy and Safety of Psoralait Versus Placebo in the Treatment of PsoriasisTerminatedNCT01149252Phase 4
• Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic ArthritisCompletedNCT01139918
• The Effect of Weight Loss on Psoriasis Area Severity Index in Adult Psoriasis PatientsWithdrawnNCT01137448Not applicable
• Effect of Weight Loss on PsoriasisCompletedNCT01137188Not applicable
• Pioglitazone in Psoriasis- A Clinical and Molecular Study.CompletedNCT01133561Not applicable
• An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept UseStatus unknownNCT01132235Phase 4
• Cross-sectional Evaluation of Biological Markers of Cardiovascular Disease in Children and Adolescents With PsoriasisStatus unknownNCT01122095
• The Effect of Algae Dunaliella Bardawil on Psoriasis (2)WithdrawnNCT01121081Phase 3
• Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of PsoriasisCompletedNCT01119339Phase 2
• A Psoriasis Plaque Test Comparing Eight Different Formulations of Vitamin D Analogues for the Treatment of PsoriasisCompletedNCT01105286Phase 1
• A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeksCompletedNCT01098721Phase 2
• A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe PsoriasisCompletedNCT01096862Phase 2
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe PsoriasisCompletedNCT01094093Phase 1
• Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar PustulosisTerminatedNCT01091051Phase 3
• Golimumab Plus UVB-311nm in PsoriasisTerminatedNCT01088698Not applicable

← Psoriasis overview